rss
J Clin Pathol 2007;60:787-793 doi:10.1136/jcp.2006.040915
  • Original article

Jamestown Canyon virus detection in human tissue specimens

  1. Huachuan Zheng1,
  2. Yoshihiro Murai2,
  3. Mei Hong2,
  4. Yuko Nakanishi2,
  5. Kazuhiro Nomoto2,
  6. Shinji Masuda3,
  7. Koichi Tsuneyama2,
  8. Yasuo Takano2
  1. 1Division of Pathology, The Second Affiliated Hospital of China Medical University, Shenyang, China
  2. 2Department of Diagnostic Pathology, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama, Toyama, Japan
  3. 3Division of Pathology, Kouserein Takaoka Hospital, Takaoka, Japan
  1. Correspondence to:
 Dr Yasuo Takano
 Department of Diagnostic Pathology, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama, Sugitani 2630, Toyama 930-0194, Japan; ytakano{at}ms.toyama-mpu.ac.jp
  • Accepted 3 August 2006
  • Published Online First 19 January 2007

Abstract

Aim: To clarify the advantages and disadvantages of different detection methods for Jamestown Canyon virus (JCV) in human tissue specimens.

Methods: Specimens of lung and gastric carcinomas, and normal lung tissue, gastric mucosa, and tonsil were examined for T-antigen, VP and agnoprotein of JCV by nested PCR, Southern blotting and sequencing. JCV load targeting T-antigen was evaluated by real-time PCR, and JCV existence morphologically by immunohistochemistry, in-situ hybridisation (ISH) and PCR. For these experiments, the JCI cell line (JCV cultured neuroblastoma cell line) was employed as positive control.

Results: In lung and gastric carcinomas, T-antigen, VP and agnoprotein of JCV could be detected by nested PCR whose products were confirmed by Southern blots and sequencing. With real-time PCR, frozen samples of gastric carcinomas gave better detection of JCV than their corresponding paraffin-embedded tissues (p<0.05). The positive rate of JCV was high in lung carcinoma, compared with normal lung tissue (p<0.05). It was the same for JCV copies in gastric carcinoma (p<0.05). Only the positive control exhibited JCV in the nucleus by ISH and immunohistochemistry. In-situ PCR showed that JCV genomic DNA was located in the nucleus of the carcinoma cell, some alveolar epithelial cells, and tonsil lymphocytes. In ISH and PCR, NBT/BCIP colouring was stronger than Fuchsin.

Conclusions: Nested PCR whose amplicons should be confirmed by Southern blot and sequencing was a comparatively sensitive approach to detect JCV genomic DNA in human non-neural tissues. Real-time PCR might be employed to quantify copy number of JCV. In-situ PCR was a good method to observe the JCV location in cells, given appropriate modulation of amplification cycles. Combinations of various approaches will be adopted to explore the oncogenic roles of JCV in malignancies.

Footnotes

  • Published Online First 19 January 2007

  • Funding: This work was partially supported by the Japanese Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research 14770072 and 15922084, the 21st Century COE Program in Japan, Japanese Smoking Research Society and National Natural Science Foundation of China (30600286).

  • Competing interests: None.

Responses to this article

Latest from JCP Education

Latest from JCP Education

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
View free sample issue >>

Free archive
The full back archive is now available for JCP. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • Latest Pathology jobs

    Latest Pathology jobs